OncoSignal at AACR 2018: OncoSignal tests for pre-clinical research
During the AACR Annual Meeting 2018, we introduced the OncoSignal tests for pre-clinical research. Please view the dedicated flyer for a summary of benefits and supporting data.
Part of these data were generated in collaboration with Charles River Laboratories (CRL). During the AACR Annual Meeting, Anja van de Stolpe (MD and co-inventor of OncoSignal pathway analysis) participated in a Charles River panel to elaborate on the meaning and purpose of signaling pathway analysis in the oncology field (see video). In addition, OncoSignal findings are now accessible through the CRL compendium